Patents by Inventor Serge Andre Dominique Rezzi

Serge Andre Dominique Rezzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10094819
    Abstract: The present invention relates generally to the field of nutrition and health. In particular, the present invention relates to a new biomarker, its use and a method that allows it to diagnose the likelihood to resist diet induced weight gain, and/or to be susceptible to a diet induced weight gain. For example, the biomarker may be trimethylamine-N-oxide.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: October 9, 2018
    Assignee: NESTEC S.A.
    Inventors: Francois-Pierre Martin, Claire L. Boulange, Ivan Montoliu Roura, Sebastiano Collino, Marc-Emmanuel Dumas, Elaine Holmes, Serge Andre Dominique Rezzi, Jeremy Nicholson, Sunil Kochhar
  • Publication number: 20180168197
    Abstract: A specific type of digestibility in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the specific type of digestibility or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the specific type of digestibility. The specific type of digestibility can be one or more of organic matter digestibility, dry matter digestibility, fiber digestibility, energy digestibility, fat digestibility, or protein digestibility.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 21, 2018
    Inventors: Rondo P Middleton, Brian M. Zanghi, Serge Andre Dominique Rezzi, Steven S. Hannah
  • Publication number: 20180168194
    Abstract: A specific type of organ health marker in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the specific type of organ health marker or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the specific type of organ health marker. The specific type of organ health marker can be one or more of phosphorus, alkaline phosphatase, aspartate aminotransferase, or gamma-glutamyltransferase.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 21, 2018
    Inventors: Rondo P. Middleton, Brian M. Zanghi, Serge Andre Dominique Rezzi, Steven S. Hannah
  • Publication number: 20180168195
    Abstract: Cholesterol, high-density lipoproteins, and low-density lipoproteins in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the cholesterol, high-density lipoproteins, or low-density lipoproteins or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates cholesterol, high-density lipoproteins, or low-density lipoproteins.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 21, 2018
    Inventors: Rondo P. Middleton, Brain M. Zanghi, Serge Andre Dominique Rezzi, Steven S. Hannah
  • Publication number: 20180169127
    Abstract: White blood cells and/or neutrophils in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the white blood cells and/or neutrophils or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the white blood cells and/or neutrophils.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 21, 2018
    Inventors: Rondo P. Middleton, Brian M. Zanghi, Serge Andre Dominique Rezzi, Steven S. Hannah
  • Publication number: 20180168196
    Abstract: A specific bacterium in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the specific type of bacterium or to decrease the amount of a compound which positively or negatively modulates the specific type of bacterium. The specific type of bacterium can be one or more of Bifidobacterium, Lactobacillus, or Clostridium perfringens.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 21, 2018
    Inventors: Rondo P. Middleton, Brian M. Zanghi, Serge Andre Dominique Rezzi, Steven S. Hannah
  • Publication number: 20180169068
    Abstract: Bone mineral content, 25(OH) vitamin D3, or 1,25(OH)2 vitamin D3 in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the bone mineral content, 25(OH) vitamin D3, or 1,25(OH)2 vitamin D3 or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the bone mineral content, 25(OH) vitamin D3, or 1,25(OH)2 vitamin D3.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 21, 2018
    Inventors: Rondo P. Middleton, Brian M. Zanghi, Serge Andre Dominique Rezzi, Steven S. Hannah
  • Publication number: 20180024149
    Abstract: The invention relates to a method, a system and kit for identifying the sample of a patient having IBD or predicting the relapse of IBD in patients based on the measurement of biomarkers in a sample of the patient. The biomarkers can be lipids or amino acids or a combination thereof.
    Type: Application
    Filed: January 22, 2016
    Publication date: January 25, 2018
    Inventors: Eduardo Schiffrin, Viral Brahmbhatt, Francois-Pierre Martin, Ivan Montoliu Roura, Serge Andre Dominique Rezzi, Jalil Benyacoub
  • Publication number: 20170370910
    Abstract: The present invention relates to a method for determining the distinctive nutritional requirements of a patient with specific nutritional needs and providing a composition meeting the distinctive nutritional requirements of said patient.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 28, 2017
    Inventors: Serge Andre Dominique Rezzi, Stephanie Blum-Sperisen, Magali Faure, Denis Breuille
  • Patent number: 9817003
    Abstract: Using NMR/MS based metabonomics and targeted lipidomics approaches the inventors have explored the metabolic phenotypes of aging and longevity in a cohort including centenarians, elderly and young adults. The inventors have identified biomarkers for a reduced risk of developing ageing related chronic inflammatory disorders and propose a method of diagnosing a lifestyle that allows delaying and/or avoiding ageing related chronic inflammatory disorders using 9-oxo-ODE as biomarker.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: November 14, 2017
    Assignee: NESTEC S.A.
    Inventors: Sebastiano Collino, Ivan Montoliu Roura, Francois-Pierre Martin, Philippe Alexandre Guy, Serge Andre Dominique Rezzi
  • Patent number: 9693942
    Abstract: The present invention relates generally to the field of enhancing skin appearance. One aspect of the invention aims to provide a composition comprising 4-oxo-2-pentenoic acid for use in the reduction or prevention of regions of the skin with darker pigmentation. The present invention also relates to cosmetic use of a composition comprising 4-oxo-2-pentenoic acid for the reduction or prevention of regions of the skin with darker pigmentation.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: July 4, 2017
    Assignee: Nestec S.A.
    Inventors: Francia Jacqueline Arce Vera, Bertrand Bourqui, Timo Buetler, Stephane Duboux, Francis Foata, Marjorie Guitard, Philippe Alexandre Guy, Nicolas Page, Serge Andre Dominique Rezzi
  • Publication number: 20170156386
    Abstract: The present invention provides a system for producing a nutritional composition (6), the system comprising (a) a measurement device (3) for determining a level of one or more nutrients in a sample (2) from a subject (7); (b) a controller (4) for calculating a required nutrient intake for the subject (7), wherein the controller (4) is operatively linked to the measurement device (3) and is configured to calculate the required nutrient intake based on the level of the nutrients in the sample (2) from the subject (7); (c) a nutritional dispenser (5) for preparing a personalized nutritional composition (6) comprising a combination of nutrients required by the subject (7); wherein the nutritional dispenser (5) is operatively linked to the controller (4) and is configured to produce the personalized nutritional composition (6) comprising the combination of nutrients based on the required nutrient intake for the subject (7) calculated by the controller (4).
    Type: Application
    Filed: May 12, 2015
    Publication date: June 8, 2017
    Applicant: NESTEC S.A.
    Inventors: Edward Baetge, Nicolas Bouche, Serge Andre Dominique Rezzi
  • Patent number: 9500660
    Abstract: The present invention relates generally to the field of nutrition and health. In particular, the present invention relates to a new biomarker, its use and a method that allows it to diagnose the likelihood to resist diet induced weight gain, and/or to be susceptible to a diet induced weight gain. For example, the biomarker may be isovalerylglycine.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: November 22, 2016
    Assignee: Nestec S.A.
    Inventors: Francois-Pierre Martin, Claire L. Boulange, Ivan Montoliu Rora, Sebastiano Collino, Marc-Emmanuel Dumas, Elaine Holmes, Serge Andre Dominique Rezzi, Jeremy Nicholson, Sunil Kochhar
  • Patent number: 9486425
    Abstract: The present invention relates generally to compositions with a health benefit. In particular, the invention relates to treatment or prevention of liver disorders. A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of liver disorders. A further subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of liver disorders linked to an insufficient activity of phase II enzymes in the liver.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: November 8, 2016
    Assignee: Nestec S.A.
    Inventors: Francia Jacqueline Arce Vera, Bertrand Bourqui, Timo Buetler, Stephane Duboux, Francis Foata, Philippe Alexandre Guy, Nicolas Page, Serge Andre Dominique Rezzi
  • Publication number: 20160245786
    Abstract: In one aspect there is provided a method for predicting a risk of unhealthy ageing in a subject, comprising: (a) determining a level of two or more lipid biomarkers in a sample from the subject, wherein the biomarkers are selected from two or more of the following groups: (i) a triacylglycerol (TAG) from TAG (46:5) to TAG (54:3); (ii) an ether phosphatidylcholine (PC-O) from PC-O(28:0) to PC-O(38:6); (iii) a sphingomyelin (SM) from SM (33:1) to SM(50:1); (iv) a phosphatidylcholine (PC) from PC (32:1) to PC (40:5); (v) a phosphatidylinositol (PI) from PI (36:1) to PI (38:3); (vi) a phosphatidylethanolamine (PE) from PE (36:2) to PE (38:4); and (b) comparing the levels of the biomarkers in the sample to reference values; wherein the levels of the biomarkers in the sample compared to the reference values are indicative of the risk of unhealthy ageing in the subject.
    Type: Application
    Filed: November 5, 2014
    Publication date: August 25, 2016
    Inventors: Sebastiano Collino, Ivan Montoliu Roura, Françios-Pierre Martin, Fiona Camille Beguelin, Serge André Dominique Rezzi
  • Patent number: 9410963
    Abstract: The present invention relates generally to the field of nutrition and health. In particular, the present invention relates to a new biomarker, its use and a method that allows it to diagnose the likelihood to resist diet induced weight gain, and/or to be susceptible to a diet induced weight gain. For example, the biomarker may be hexanoylglycine.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: August 9, 2016
    Assignee: Nestec S.A.
    Inventors: Francois-Pierre Martin, Claire L. Boulange, Ivan Montoliu Roura, Sebastiano Collino, Marc-Emmanuel Dumas, Elaine Holmes, Serge Andre Dominique Rezzi, Jeremy Nicholson, Sunil Kochhar
  • Publication number: 20160166638
    Abstract: The present invention relates to complexes of lactoferrin, osteopontin and iron. In particular the invention relates to a composition comprising at least 2 g/kg of lactoferrin-osteopontin-iron complex for use in the treatment or prevention of iron deficiency. An aspect of the invention is a fortified foodstuff comprising a lactoferrin- osteopontin-iron complex. Further aspects of the invention are a process for fortifying a food product with iron and the use of a lactoferrin-osteopontin-iron complex to fortify a food product with iron.
    Type: Application
    Filed: June 17, 2014
    Publication date: June 16, 2016
    Inventors: Peter Kastenmayer, Sunil Kochhar, Serge Andre Dominique Rezzi
  • Patent number: 9341615
    Abstract: Using NMR/MS based metabonomics and targeted lipidomics approaches the inventors have explored the metabolic phenotypes of aging and longevity in a cohort including centenarians, elderly and young adults. The inventors have identified biomarkers for a reduced risk of developing ageing related chronic inflammatory disorders and propose a method of diagnosing a lifestyle that allows delaying and/or avoiding ageing related chronic inflammatory disorders using PC-O 40:1 as biomarker.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: May 17, 2016
    Assignee: NESTEC S.A.
    Inventors: Sebastiano Collino, Ivan Montoliu Roura, Francois-Pierre Martin, Philippe Alexandre Guy, Serge Andre Dominique Rezzi
  • Patent number: 9322821
    Abstract: Using NMR/MS based metabonomics and targeted lipidomics approaches the inventors have explored the metabolic phenotypes of aging and longevity in a cohort including centenarians, elderly and young adults. The invention provides biomarkers for a reduced risk of developing ageing related chronic inflammatory disorders and propose an in vitro method of diagnosing a lifestyle that allows to delay and/or avoid ageing related chronic inflammatory disorders using p-cresol sulphate as biomarker.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: April 26, 2016
    Assignee: NESTEC S.A.
    Inventors: Sebastiano Collino, Ivan Montoliu Roura, Francois-Pierre Martin, Philippe Alexandre Guy, Serge Andre Dominique Rezzi
  • Patent number: 9301941
    Abstract: The invention provides methods for one or more of preventing or treating sarcopenia and muscle atrophy in animals. The methods comprise administering isoflavones to the animals, preferably in amounts of from about 0.001 to about 10 g/kg/day.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: April 5, 2016
    Assignee: Nestec S. A
    Inventors: Yuanlong Pan, Sunil Kochhar, Serge Andre Dominique Rezzi, Francois-Pierre Martin, Emma Peré-Trepat, Sebastiano Collino, Francia Arce Vera